Show PDB file:   
         Plain Text   HTML   (compressed file size)
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(-)Asymmetric Unit
(-)Asym. Unit - sites
(-)Biological Unit 1
(-)Biol. Unit 1 - sites
(-)Biological Unit 2
collapse expand < >
Image Asymmetric Unit
Asymmetric Unit  (Jmol Viewer)
Image Asym. Unit - sites
Asym. Unit - sites  (Jmol Viewer)
Image Biological Unit 1
Biological Unit 1  (Jmol Viewer)
Image Biol. Unit 1 - sites
Biol. Unit 1 - sites  (Jmol Viewer)
Image Biological Unit 2
Biological Unit 2  (Jmol Viewer)

(-) Description

Title :  CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN T790M MUTATION IN COMPLEX WITH AEE788
 
Authors :  C. -H. Yun, K. E. Mengwasser, A. V. Toms, M. S. Woo, H. Greulich, K. -K. Wong, M. Meyerson, M. J. Eck
Date :  01 Jul 07  (Deposition) - 22 Jan 08  (Release) - 24 Feb 09  (Revision)
Method :  X-RAY DIFFRACTION
Resolution :  3.05
Chains :  Asym. Unit :  A,B
Biol. Unit 1:  A  (1x)
Biol. Unit 2:  B  (1x)
Keywords :  Cell Cycle, Atp-Binding, Transferase, Nucleotide-Binding, Alternative Splicing, Egfr, T790M, Kinase, Aee788, Receptor, Tyrosine-Protein Kinase, Epidermal Growth Factor, Phosphorylation, Disease Mutation, Anti-Oncogene, Transmembrane (Keyword Search: [Gene Ontology, PubMed, Web (Google))
 
Reference :  C. -H. Yun, K. E. Mengwasser, A. V. Toms, M. S. Woo, H. Greulich, K. -K. Wong, M. Meyerson, M. J. Eck
The T790M Mutation In Egfr Kinase Causes Drug Resistance By Increasing The Affinity For Atp.
Proc. Natl. Acad. Sci. Usa V. 105 2070 2008
PubMed-ID: 18227510  |  Reference-DOI: 10.1073/PNAS.0709662105

(-) Compounds

Molecule 1 - EPIDERMAL GROWTH FACTOR RECEPTOR
    ChainsA, B
    EC Number2.7.1.112
    EngineeredYES
    Expression SystemSPODOPTERA FRUGIPERDA
    Expression System Cell LineSF9
    Expression System PlasmidPACG2T
    Expression System Taxid7108
    Expression System Vector TypeBACULOVIRUS
    FragmentKINASE DOMAIN, RESIDUES 695-1022
    MutationYES
    Organism CommonHUMAN
    Organism ScientificHOMO SAPIENS
    Organism Taxid9606
    Other DetailsEGFR 696-1022 T790M
    Other Details - SourceEGFR 696-1022 T790M
    SynonymRECEPTOR TYROSINE-PROTEIN KINASE ERBB-1

 Structural Features

(-) Chains, Units

  12
Asymmetric Unit AB
Biological Unit 1 (1x)A 
Biological Unit 2 (1x) B

Summary Information (see also Sequences/Alignments below)

(-) Ligands, Modified Residues, Ions  (1, 1)

Asymmetric Unit (1, 1)
No.NameCountTypeFull Name
1AEE1Ligand/Ion6-{4-[(4-ETHYLPIPERAZIN-1-YL)METHYL]PHENYL}-N-[(1R)-1-PHENYLETHYL]-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE
Biological Unit 1 (1, 1)
No.NameCountTypeFull Name
1AEE1Ligand/Ion6-{4-[(4-ETHYLPIPERAZIN-1-YL)METHYL]PHENYL}-N-[(1R)-1-PHENYLETHYL]-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE
Biological Unit 2 (0, 0)
No.NameCountTypeFull Name
1AEE-1Ligand/Ion6-{4-[(4-ETHYLPIPERAZIN-1-YL)METHYL]PHENYL}-N-[(1R)-1-PHENYLETHYL]-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE

(-) Sites  (1, 1)

Asymmetric Unit (1, 1)
No.NameEvidenceResiduesDescription
1AC1SOFTWARELEU A:718 , ALA A:743 , LYS A:745 , LEU A:788 , GLN A:791 , LEU A:792 , MET A:793 , PRO A:794 , GLY A:796 , ASP A:800 , GLU A:804 , LEU A:844 , THR A:854 , ASP A:855 , HOH A:3016 , HOH A:3038BINDING SITE FOR RESIDUE AEE A2017

(-) SS Bonds  (0, 0)

(no "SS Bond" information available for 2JIU)

(-) Cis Peptide Bonds  (0, 0)

(no "Cis Peptide Bond" information available for 2JIU)

 Sequence-Structure Mapping

(-) SAPs(SNPs)/Variants  (25, 50)

Asymmetric Unit (25, 50)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_026084E709AEGFR_HUMANPolymorphism397517085A/BE709A
02UniProtVAR_069498E709GEGFR_HUMANPolymorphism397517085A/BE709G
03UniProtVAR_026085E709KEGFR_HUMANPolymorphism727504256A/BE709K
04UniProtVAR_026086G719AEGFR_HUMANPolymorphism121913428A/BG719A
05UniProtVAR_026087G719CEGFR_HUMANPolymorphism28929495A/BG719C
06UniProtVAR_026088G719DEGFR_HUMANPolymorphism121913428A/BG719D
07UniProtVAR_019297G719SEGFR_HUMANPolymorphism28929495A/BG719S
08UniProtVAR_026089G724SEGFR_HUMANUnclassified  ---A/BG724S
09UniProtVAR_026090E734KEGFR_HUMANPolymorphism121913420A/BE734K
10UniProtVAR_026093L747FEGFR_HUMANUnclassified  ---A/BL747F
11UniProtVAR_026095R748PEGFR_HUMANUnclassified  ---A/BR748P
12UniProtVAR_069502S768IEGFR_HUMANPolymorphism121913465A/BS768I
13UniProtVAR_069503V769MEGFR_HUMANPolymorphism147149347A/BV769M
14UniProtVAR_026097Q787REGFR_HUMANUnclassified  ---A/BQ787R
15UniProtVAR_026098T790MEGFR_HUMANPolymorphism121434569A/BM790M
16UniProtVAR_026099L833VEGFR_HUMANPolymorphism397517126A/BL833V
17UniProtVAR_026100V834LEGFR_HUMANPolymorphism397517127A/BV834L
18UniProtVAR_069504H835LEGFR_HUMANPolymorphism397517128A/BH835L
19UniProtVAR_069505L838VEGFR_HUMANPolymorphism864621996A/BL838V
20UniProtVAR_026101L858MEGFR_HUMANPolymorphism121913443A/BL858M
21UniProtVAR_019298L858REGFR_HUMANPolymorphism121434568A/BL858R
22UniProtVAR_026102L861QEGFR_HUMANPolymorphism121913444A/BL861Q
23UniProtVAR_026103G873EEGFR_HUMANUnclassified  ---A/BG873E
24UniProtVAR_019299R962GEGFR_HUMANPolymorphism17337451A/BR962G
25UniProtVAR_019300H988PEGFR_HUMANPolymorphism17290699A/BH988P

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 1 (25, 25)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_026084E709AEGFR_HUMANPolymorphism397517085AE709A
02UniProtVAR_069498E709GEGFR_HUMANPolymorphism397517085AE709G
03UniProtVAR_026085E709KEGFR_HUMANPolymorphism727504256AE709K
04UniProtVAR_026086G719AEGFR_HUMANPolymorphism121913428AG719A
05UniProtVAR_026087G719CEGFR_HUMANPolymorphism28929495AG719C
06UniProtVAR_026088G719DEGFR_HUMANPolymorphism121913428AG719D
07UniProtVAR_019297G719SEGFR_HUMANPolymorphism28929495AG719S
08UniProtVAR_026089G724SEGFR_HUMANUnclassified  ---AG724S
09UniProtVAR_026090E734KEGFR_HUMANPolymorphism121913420AE734K
10UniProtVAR_026093L747FEGFR_HUMANUnclassified  ---AL747F
11UniProtVAR_026095R748PEGFR_HUMANUnclassified  ---AR748P
12UniProtVAR_069502S768IEGFR_HUMANPolymorphism121913465AS768I
13UniProtVAR_069503V769MEGFR_HUMANPolymorphism147149347AV769M
14UniProtVAR_026097Q787REGFR_HUMANUnclassified  ---AQ787R
15UniProtVAR_026098T790MEGFR_HUMANPolymorphism121434569AM790M
16UniProtVAR_026099L833VEGFR_HUMANPolymorphism397517126AL833V
17UniProtVAR_026100V834LEGFR_HUMANPolymorphism397517127AV834L
18UniProtVAR_069504H835LEGFR_HUMANPolymorphism397517128AH835L
19UniProtVAR_069505L838VEGFR_HUMANPolymorphism864621996AL838V
20UniProtVAR_026101L858MEGFR_HUMANPolymorphism121913443AL858M
21UniProtVAR_019298L858REGFR_HUMANPolymorphism121434568AL858R
22UniProtVAR_026102L861QEGFR_HUMANPolymorphism121913444AL861Q
23UniProtVAR_026103G873EEGFR_HUMANUnclassified  ---AG873E
24UniProtVAR_019299R962GEGFR_HUMANPolymorphism17337451AR962G
25UniProtVAR_019300H988PEGFR_HUMANPolymorphism17290699AH988P

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)
Biological Unit 2 (25, 25)
  dbSNPPDB
No.SourceVariant IDVariantUniProt IDStatusIDChainVariant
01UniProtVAR_026084E709AEGFR_HUMANPolymorphism397517085BE709A
02UniProtVAR_069498E709GEGFR_HUMANPolymorphism397517085BE709G
03UniProtVAR_026085E709KEGFR_HUMANPolymorphism727504256BE709K
04UniProtVAR_026086G719AEGFR_HUMANPolymorphism121913428BG719A
05UniProtVAR_026087G719CEGFR_HUMANPolymorphism28929495BG719C
06UniProtVAR_026088G719DEGFR_HUMANPolymorphism121913428BG719D
07UniProtVAR_019297G719SEGFR_HUMANPolymorphism28929495BG719S
08UniProtVAR_026089G724SEGFR_HUMANUnclassified  ---BG724S
09UniProtVAR_026090E734KEGFR_HUMANPolymorphism121913420BE734K
10UniProtVAR_026093L747FEGFR_HUMANUnclassified  ---BL747F
11UniProtVAR_026095R748PEGFR_HUMANUnclassified  ---BR748P
12UniProtVAR_069502S768IEGFR_HUMANPolymorphism121913465BS768I
13UniProtVAR_069503V769MEGFR_HUMANPolymorphism147149347BV769M
14UniProtVAR_026097Q787REGFR_HUMANUnclassified  ---BQ787R
15UniProtVAR_026098T790MEGFR_HUMANPolymorphism121434569BM790M
16UniProtVAR_026099L833VEGFR_HUMANPolymorphism397517126BL833V
17UniProtVAR_026100V834LEGFR_HUMANPolymorphism397517127BV834L
18UniProtVAR_069504H835LEGFR_HUMANPolymorphism397517128BH835L
19UniProtVAR_069505L838VEGFR_HUMANPolymorphism864621996BL838V
20UniProtVAR_026101L858MEGFR_HUMANPolymorphism121913443BL858M
21UniProtVAR_019298L858REGFR_HUMANPolymorphism121434568BL858R
22UniProtVAR_026102L861QEGFR_HUMANPolymorphism121913444BL861Q
23UniProtVAR_026103G873EEGFR_HUMANUnclassified  ---BG873E
24UniProtVAR_019299R962GEGFR_HUMANPolymorphism17337451BR962G
25UniProtVAR_019300H988PEGFR_HUMANPolymorphism17290699BH988P

  SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

(-) PROSITE Motifs  (2, 4)

Asymmetric Unit (2, 4)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1PROTEIN_KINASE_ATPPS00107 Protein kinases ATP-binding region signature.EGFR_HUMAN718-745
 
  2A:718-745
B:718-745
2PROTEIN_KINASE_TYRPS00109 Tyrosine protein kinases specific active-site signature.EGFR_HUMAN833-845
 
  2A:833-845
B:833-845
Biological Unit 1 (2, 2)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1PROTEIN_KINASE_ATPPS00107 Protein kinases ATP-binding region signature.EGFR_HUMAN718-745
 
  1A:718-745
-
2PROTEIN_KINASE_TYRPS00109 Tyrosine protein kinases specific active-site signature.EGFR_HUMAN833-845
 
  1A:833-845
-
Biological Unit 2 (2, 2)
 PROSITEUniProtKBPDB
No.IDACDescriptionIDLocationCountLocation
1PROTEIN_KINASE_ATPPS00107 Protein kinases ATP-binding region signature.EGFR_HUMAN718-745
 
  1-
B:718-745
2PROTEIN_KINASE_TYRPS00109 Tyrosine protein kinases specific active-site signature.EGFR_HUMAN833-845
 
  1-
B:833-845

(-) Exons   (8, 16)

Asymmetric Unit (8, 16)
 ENSEMBLUniProtKBPDB
No.Transcript IDExonExon IDGenome LocationLengthIDLocationLengthCountLocationLength
1.1eENST000002754931eENSE00001841347chr7:55086794-55087058265EGFR_HUMAN1-30300--
1.5ENST000002754935ENSE00001715021chr7:55209979-55210130152EGFR_HUMAN30-80510--
1.6ENST000002754936ENSE00001704157chr7:55210998-55211181184EGFR_HUMAN81-142620--
1.7bENST000002754937bENSE00001798125chr7:55214299-55214433135EGFR_HUMAN142-187460--
1.8ENST000002754938ENSE00001683983chr7:55218987-5521905569EGFR_HUMAN187-210240--
1.9ENST000002754939ENSE00001652975chr7:55220239-55220357119EGFR_HUMAN210-249400--
1.10ENST0000027549310ENSE00001623732chr7:55221704-55221845142EGFR_HUMAN250-297480--
1.11ENST0000027549311ENSE00001751179chr7:55223523-55223639117EGFR_HUMAN297-336400--
1.12ENST0000027549312ENSE00001084929chr7:55224226-55224352127EGFR_HUMAN336-378430--
1.13aENST0000027549313aENSE00001084931chr7:55224452-5522452574EGFR_HUMAN378-403260--
1.14ENST0000027549314ENSE00001084926chr7:55225356-5522544691EGFR_HUMAN403-433310--
1.15ENST0000027549315ENSE00001084941chr7:55227832-55228031200EGFR_HUMAN433-500680--
1.16ENST0000027549316ENSE00001084939chr7:55229192-55229324133EGFR_HUMAN500-544450--
1.17ENST0000027549317ENSE00001084927chr7:55231426-5523151691EGFR_HUMAN544-574310--
1.18ENST0000027549318ENSE00001627115chr7:55232973-55233130158EGFR_HUMAN575-627530--
1.21ENST0000027549321ENSE00001768076chr7:55238868-5523890639EGFR_HUMAN627-640140--
1.23ENST0000027549323ENSE00001699330chr7:55240676-55240817142EGFR_HUMAN640-687480--
1.24ENST0000027549324ENSE00001778519chr7:55241614-55241736123EGFR_HUMAN688-728412A:696-728
B:695-728
33
34
1.25ENST0000027549325ENSE00001756460chr7:55242415-5524251399EGFR_HUMAN729-761332A:729-761
B:729-761
33
33
1.26ENST0000027549326ENSE00001601336chr7:55248986-55249171186EGFR_HUMAN762-823622A:762-823
B:762-823
62
62
1.27ENST0000027549327ENSE00001681524chr7:55259412-55259567156EGFR_HUMAN824-875522A:824-875
B:824-875
52
52
1.28aENST0000027549328aENSE00001631695chr7:55260459-5526053476EGFR_HUMAN876-901262A:876-901
B:876-901
26
26
1.29ENST0000027549329ENSE00001779947chr7:55266410-55266556147EGFR_HUMAN901-950502A:901-950
B:901-950
50
50
1.30aENST0000027549330aENSE00001790701chr7:55268009-5526810698EGFR_HUMAN950-982332A:950-982
B:950-982
33
33
1.31ENST0000027549331ENSE00001801208chr7:55268881-55269048168EGFR_HUMAN983-1038562A:983-1016 (gaps)
B:983-1004
34
22
1.32ENST0000027549332ENSE00001773562chr7:55269428-5526947548EGFR_HUMAN1039-1054160--
1.33aENST0000027549333aENSE00001795780chr7:55270210-55270318109EGFR_HUMAN1055-1091370--
1.34bENST0000027549334bENSE00001245887chr7:55272949-552793216373EGFR_HUMAN1091-12101200--

(-) Sequences/Alignments

Asymmetric Unit
   Reformat: Number of residues per line =  ('0' or empty: single-line sequence representation)
  Number of residues per labelling interval =   
  UniProt sequence: complete  aligned part    
   Show mapping: SCOP domains CATH domains Pfam domains Secondary structure (by author)
SAPs(SNPs) PROSITE motifs Exons
(details for a mapped element are shown in a popup box when the mouse pointer rests over it)
Chain A from PDB  Type:PROTEIN  Length:304
 aligned with EGFR_HUMAN | P00533 from UniProtKB/Swiss-Prot  Length:1210

    Alignment length:321
                                   705       715       725       735       745       755       765       775       785       795       805       815       825       835       845       855       865       875       885       895       905       915       925       935       945       955       965       975       985       995      1005      1015 
          EGFR_HUMAN    696 GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEY 1016
               SCOP domains d2jiua_ A: automated matches                                                                                                                                                                                                                                                                                                      SCOP domains
               CATH domains 2jiuA01 A:696-792 Phosphorylase Kinase; domain 1                                                 2jiuA02 A:793-1010 Transferase(Phosphotransferase) domain 1                                                                                                                                                               ------ CATH domains
               Pfam domains --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author ................eeeeeeee.....eeeeeee........eeeeeee......hhhhhhhhhhhhhhhhh.......eeeeee...eeeeee.....hhhhhhhhh....hhhhhhhhhhhhhhhhhhhhh........hhh.eeeee..eeee.......................hhhhhhhhhhhhh..hhhhhhhhhhhhhhhhhh............hhhhhhhhh.........hhhhhhhhhhh...hhhhh.hhhhhhhhhhhhhhhhhhh..............-----------------....... Sec.struct. author
             SAPs(SNPs) (1) -------------A---------A----S---------K------------FP-------------------IM-----------------R--M------------------------------------------VLL--V-------------------M--Q-----------E----------------------------------------------------------------------------------------G-------------------------P---------------------------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) -------------G---------C------------------------------------------------------------------------------------------------------------------------------------------R-------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs) (2)
             SAPs(SNPs) (3) -------------K---------D--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs) (3)
             SAPs(SNPs) (4) -----------------------S--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs) (4)
                    PROSITE ----------------------PROTEIN_KINASE_ATP          ---------------------------------------------------------------------------------------PROTEIN_KINAS--------------------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.24  PDB: A:696-728        Exon 1.25  PDB: A:729-761        Exon 1.26  PDB: A:762-823 UniProt: 762-823                    Exon 1.27  PDB: A:824-875 UniProt: 824-875          Exon 1.28a  PDB: A:876-901------------------------------------------------Exon 1.30a  PDB: A:950-982       Exon 1.31  PDB: A:983-1016 (gaps)  Transcript 1 (1)
           Transcript 1 (2) -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Exon 1.29  PDB: A:901-950 UniProt: 901-950        ------------------------------------------------------------------ Transcript 1 (2)
                2jiu A  696 GEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSP-----------------VVDADEY 1016
                                   705       715       725       735       745       755       765       775       785       795       805       815       825       835       845       855       865       875       885       895       905       915       925       935       945       955       965       975       985      |  -         -    | 1015 
                                                                                                                                                                                                                                                                                                                                  992              1010      

Chain B from PDB  Type:PROTEIN  Length:310
 aligned with EGFR_HUMAN | P00533 from UniProtKB/Swiss-Prot  Length:1210

    Alignment length:310
                                   704       714       724       734       744       754       764       774       784       794       804       814       824       834       844       854       864       874       884       894       904       914       924       934       944       954       964       974       984       994      1004
          EGFR_HUMAN    695 SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDE 1004
               SCOP domains d2jiub_ B: automated matches                                                                                                                                                                                                                                                                                           SCOP domains
               CATH domains 2jiuB01 B:695-792 Phosphorylase Kinase; domain 1                                                  2jiuB02 B:793-992 Transferase(Phosphotransferase) domain 1                                                                                                                                              ------------ CATH domains
           Pfam domains (1) -----------------Pkinase_Tyr-2jiuB01 B:712-968                                                                                                                                                                                                                                    ------------------------------------ Pfam domains (1)
           Pfam domains (2) -----------------Pkinase_Tyr-2jiuB02 B:712-968                                                                                                                                                                                                                                    ------------------------------------ Pfam domains (2)
         Sec.struct. author .............hhh.eeeeeeeee....eeeeeee........eeeeeee.....hhhhhhhhhhhhhhhhhh.......eeeee.....eeeee.....hhhhhhhh.....hhhhhhhhhhhhhhhhhhhhhh.......hhh.eeeee..eeee.......................hhhhhhhhhhh....hhhhhhhhhhhhhhhhhh............hhhhhh............hhhhhhhhhhh...hhhhh.hhhhhhhhhhhhhhhhhhhh...............hhhhhhhh.. Sec.struct. author
             SAPs(SNPs) (1) --------------A---------A----S---------K------------FP-------------------IM-----------------R--M------------------------------------------VLL--V-------------------M--Q-----------E----------------------------------------------------------------------------------------G-------------------------P---------------- SAPs(SNPs) (1)
             SAPs(SNPs) (2) --------------G---------C------------------------------------------------------------------------------------------------------------------------------------------R-------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs) (2)
             SAPs(SNPs) (3) --------------K---------D--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs) (3)
             SAPs(SNPs) (4) ------------------------S--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SAPs(SNPs) (4)
                    PROSITE -----------------------PROTEIN_KINASE_ATP          ---------------------------------------------------------------------------------------PROTEIN_KINAS--------------------------------------------------------------------------------------------------------------------------------------------------------------- PROSITE
           Transcript 1 (1) Exon 1.24  PDB: B:695-728         Exon 1.25  PDB: B:729-761        Exon 1.26  PDB: B:762-823 UniProt: 762-823                    Exon 1.27  PDB: B:824-875 UniProt: 824-875          Exon 1.28a  PDB: B:876-901------------------------------------------------Exon 1.30a  PDB: B:950-982       Exon 1.31 [INCOMPLETE] Transcript 1 (1)
           Transcript 1 (2) --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Exon 1.29  PDB: B:901-950 UniProt: 901-950        ------------------------------------------------------ Transcript 1 (2)
                2jiu B  695 SGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDE 1004
                                   704       714       724       734       744       754       764       774       784       794       804       814       824       834       844       854       864       874       884       894       904       914       924       934       944       954       964       974       984       994      1004

   Legend:   → Mismatch (orange background)
  - → Gap (green background, '-', border residues have a numbering label)
    → Modified Residue (blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
  x → Chemical Group (purple background, 'x', labelled with number + name, e.g. ACE or NH2)
  extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '|'

 Classification and Annotation

(-) SCOP Domains  (1, 2)

Asymmetric Unit

(-) CATH Domains  (2, 4)

Asymmetric Unit
(-)
Class: Alpha Beta (26913)

(-) Pfam Domains  (1, 2)

Asymmetric Unit
(-)
Clan: PKinase (934)

(-) Gene Ontology  (111, 111)

Asymmetric Unit(hide GO term definitions)
Chain A,B   (EGFR_HUMAN | P00533)
molecular function
    GO:0005524    ATP binding    Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
    GO:0004709    MAP kinase kinase kinase activity    Catalysis of the phosphorylation and activation of a MAP kinase kinase; each MAP kinase kinase can be phosphorylated by any of several MAP kinase kinase kinases.
    GO:0005088    Ras guanyl-nucleotide exchange factor activity    Stimulates the exchange of guanyl nucleotides associated with a GTPase of the Ras superfamily. Under normal cellular physiological conditions, the concentration of GTP is higher than that of GDP, favoring the replacement of GDP by GTP in association with the GTPase.
    GO:0051015    actin filament binding    Interacting selectively and non-covalently with an actin filament, also known as F-actin, a helical filamentous polymer of globular G-actin subunits.
    GO:0003682    chromatin binding    Interacting selectively and non-covalently with chromatin, the network of fibers of DNA, protein, and sometimes RNA, that make up the chromosomes of the eukaryotic nucleus during interphase.
    GO:0003690    double-stranded DNA binding    Interacting selectively and non-covalently with double-stranded DNA.
    GO:0019899    enzyme binding    Interacting selectively and non-covalently with any enzyme.
    GO:0005006    epidermal growth factor-activated receptor activity    Combining with an epidermal growth factor and transmitting the signal across the plasma membrane to initiate a change in cell activity.
    GO:0042802    identical protein binding    Interacting selectively and non-covalently with an identical protein or proteins.
    GO:0016301    kinase activity    Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.
    GO:0030235    nitric-oxide synthase regulator activity    Modulates the activity of nitric oxide synthase.
    GO:0000166    nucleotide binding    Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.
    GO:0046934    phosphatidylinositol-4,5-bisphosphate 3-kinase activity    Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + ATP = a 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + ADP + 2 H(+).
    GO:0005515    protein binding    Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
    GO:0046982    protein heterodimerization activity    Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
    GO:0004672    protein kinase activity    Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP.
    GO:0019903    protein phosphatase binding    Interacting selectively and non-covalently with any protein phosphatase.
    GO:0004713    protein tyrosine kinase activity    Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate.
    GO:0004871    signal transducer activity    Conveys a signal across a cell to trigger a change in cell function or state. A signal is a physical entity or change in state that is used to transfer information in order to trigger a response.
    GO:0004716    signal transducer, downstream of receptor, with protein tyrosine kinase activity    Conveys a signal from an upstream receptor or intracellular signal transducer by catalysis of the reaction: ATP + a protein-L-tyrosine = ADP + a protein-L-tyrosine phosphate.
    GO:0016740    transferase activity    Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.
    GO:0004714    transmembrane receptor protein tyrosine kinase activity    Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP + a protein-L-tyrosine = ADP + a protein-L-tyrosine phosphate.
    GO:0004888    transmembrane signaling receptor activity    Combining with an extracellular or intracellular signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity or state as part of signal transduction.
    GO:0031625    ubiquitin protein ligase binding    Interacting selectively and non-covalently with a ubiquitin protein ligase enzyme, any of the E3 proteins.
biological process
    GO:0038128    ERBB2 signaling pathway    A series of molecular signals initiated by binding of a ligand to a member of the ERBB family of receptors on the surface of a cell, where the signal is transmitted by ERBB2. The pathway ends with regulation of a downstream cellular process, e.g. transcription. ERBB2 receptors are themselves unable to bind to ligands, but act as a signal-amplifying tyrosine kinase within a heterodimeric pair.
    GO:0000165    MAPK cascade    An intracellular protein kinase cascade containing at least a MAPK, a MAPKK and a MAP3K. The cascade can also contain two additional tiers: the upstream MAP4K and the downstream MAP Kinase-activated kinase (MAPKAPK). The kinases in each tier phosphorylate and activate the kinases in the downstream tier to transmit a signal within a cell.
    GO:0000186    activation of MAPKK activity    The initiation of the activity of the inactive enzyme MAP kinase kinase (MAPKK).
    GO:0043006    activation of phospholipase A2 activity by calcium-mediated signaling    A series of molecular signals that leads to the upregulation of calcium-dependent phospholipase A2 activity in response to the signal.
    GO:0007202    activation of phospholipase C activity    The initiation of the activity of the inactive enzyme phospolipase C as the result of a series of molecular signals generated as a consequence of a G-protein coupled receptor binding to its physiological ligand.
    GO:0000902    cell morphogenesis    The developmental process in which the size or shape of a cell is generated and organized.
    GO:0008283    cell proliferation    The multiplication or reproduction of cells, resulting in the expansion of a cell population.
    GO:0007166    cell surface receptor signaling pathway    A series of molecular signals initiated by activation of a receptor on the surface of a cell. The pathway begins with binding of an extracellular ligand to a cell surface receptor, or for receptors that signal in the absence of a ligand, by ligand-withdrawal or the activity of a constitutively active receptor. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
    GO:0071230    cellular response to amino acid stimulus    Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an amino acid stimulus. An amino acid is a carboxylic acids containing one or more amino groups.
    GO:0071364    cellular response to epidermal growth factor stimulus    Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an epidermal growth factor stimulus.
    GO:0071392    cellular response to estradiol stimulus    Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen.
    GO:0021795    cerebral cortex cell migration    The orderly movement of cells from one site to another in the cerebral cortex.
    GO:0048546    digestive tract morphogenesis    The process in which the anatomical structures of the digestive tract are generated and organized. The digestive tract is the anatomical structure through which food passes and is processed.
    GO:0001892    embryonic placenta development    The embryonically driven process whose specific outcome is the progression of the placenta over time, from its formation to the mature structure. The placenta is an organ of metabolic interchange between fetus and mother, partly of embryonic origin and partly of maternal origin.
    GO:0007173    epidermal growth factor receptor signaling pathway    A series of molecular signals initiated by binding of a ligand to the tyrosine kinase receptor EGFR (ERBB1) on the surface of a cell. The pathway ends with regulation of a downstream cellular process, e.g. transcription.
    GO:0008544    epidermis development    The process whose specific outcome is the progression of the epidermis over time, from its formation to the mature structure. The epidermis is the outer epithelial layer of an animal, it may be a single layer that produces an extracellular material (e.g. the cuticle of arthropods) or a complex stratified squamous epithelium, as in the case of many vertebrate species.
    GO:0061029    eyelid development in camera-type eye    The progression of the eyelid in a camera-type eye from its formation to the mature state. The eyelid is a membranous cover that helps protect and lubricate the eye.
    GO:0001942    hair follicle development    The process whose specific outcome is the progression of the hair follicle over time, from its formation to the mature structure. A hair follicle is a tube-like opening in the epidermis where the hair shaft develops and into which the sebaceous glands open.
    GO:0007611    learning or memory    The acquisition and processing of information and/or the storage and retrieval of this information over time.
    GO:0060571    morphogenesis of an epithelial fold    The morphogenetic process in which an epithelial sheet bends along a linear axis.
    GO:0007275    multicellular organism development    The biological process whose specific outcome is the progression of a multicellular organism over time from an initial condition (e.g. a zygote or a young adult) to a later condition (e.g. a multicellular animal or an aged adult).
    GO:0043066    negative regulation of apoptotic process    Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
    GO:0042059    negative regulation of epidermal growth factor receptor signaling pathway    Any process that stops, prevents, or reduces the frequency, rate or extent of epidermal growth factor receptor signaling pathway activity.
    GO:0042177    negative regulation of protein catabolic process    Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a protein by the destruction of the native, active configuration, with or without the hydrolysis of peptide bonds.
    GO:0001503    ossification    The formation of bone or of a bony substance, or the conversion of fibrous tissue or of cartilage into bone or a bony substance.
    GO:0018108    peptidyl-tyrosine phosphorylation    The phosphorylation of peptidyl-tyrosine to form peptidyl-O4'-phospho-L-tyrosine.
    GO:0046854    phosphatidylinositol phosphorylation    The process of introducing one or more phosphate groups into a phosphatidylinositol, any glycerophosphoinositol having one phosphatidyl group esterified to one of the hydroxy groups of inositol.
    GO:0048015    phosphatidylinositol-mediated signaling    A series of molecular signals in which a cell uses a phosphatidylinositol-mediated signaling to convert a signal into a response. Phosphatidylinositols include phosphatidylinositol (PtdIns) and its phosphorylated derivatives.
    GO:0016310    phosphorylation    The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide.
    GO:0045739    positive regulation of DNA repair    Any process that activates or increases the frequency, rate or extent of DNA repair.
    GO:0045740    positive regulation of DNA replication    Any process that activates or increases the frequency, rate or extent of DNA replication.
    GO:0070374    positive regulation of ERK1 and ERK2 cascade    Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
    GO:0043547    positive regulation of GTPase activity    Any process that activates or increases the activity of a GTPase.
    GO:0043406    positive regulation of MAP kinase activity    Any process that activates or increases the frequency, rate or extent of MAP kinase activity.
    GO:0035413    positive regulation of catenin import into nucleus    Any process that increases the rate, frequency or extent of the directed movement of a catenin protein from the cytoplasm into the nucleus.
    GO:0030307    positive regulation of cell growth    Any process that activates or increases the frequency, rate, extent or direction of cell growth.
    GO:0030335    positive regulation of cell migration    Any process that activates or increases the frequency, rate or extent of cell migration.
    GO:0008284    positive regulation of cell proliferation    Any process that activates or increases the rate or extent of cell proliferation.
    GO:0031659    positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle    Any process that activates or increases the frequency, rate or extent of cyclin-dependent protein serine/threonine kinase activity contributing to the G1/S transition of the cell cycle.
    GO:0050679    positive regulation of epithelial cell proliferation    Any process that activates or increases the rate or extent of epithelial cell proliferation.
    GO:0048146    positive regulation of fibroblast proliferation    Any process that activates or increases the frequency, rate or extent of multiplication or reproduction of fibroblast cells.
    GO:0045429    positive regulation of nitric oxide biosynthetic process    Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of nitric oxide.
    GO:0042327    positive regulation of phosphorylation    Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to a molecule.
    GO:1903800    positive regulation of production of miRNAs involved in gene silencing by miRNA    Any process that activates or increases the frequency, rate or extent of production of miRNAs involved in gene silencing by miRNA.
    GO:0051897    positive regulation of protein kinase B signaling    Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B.
    GO:0001934    positive regulation of protein phosphorylation    Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
    GO:0045944    positive regulation of transcription from RNA polymerase II promoter    Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter.
    GO:0046777    protein autophosphorylation    The phosphorylation by a protein of one or more of its own amino acid residues (cis-autophosphorylation), or residues on an identical protein (trans-autophosphorylation).
    GO:0051205    protein insertion into membrane    The process that results in the incorporation of a protein into a biological membrane. Incorporation in this context means having some part or covalently attached group that is inserted into the the hydrophobic region of one or both bilayers.
    GO:0006468    protein phosphorylation    The process of introducing a phosphate group on to a protein.
    GO:2000145    regulation of cell motility    Any process that modulates the frequency, rate or extent of cell motility.
    GO:0042127    regulation of cell proliferation    Any process that modulates the frequency, rate or extent of cell proliferation.
    GO:0050999    regulation of nitric-oxide synthase activity    Any process that modulates the activity of the enzyme nitric-oxide synthase.
    GO:0050730    regulation of peptidyl-tyrosine phosphorylation    Any process that modulates the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine.
    GO:0014066    regulation of phosphatidylinositol 3-kinase signaling    Any process that modulates the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
    GO:0070141    response to UV-A    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a UV-A radiation stimulus. UV-A radiation (UV-A light) spans the wavelengths 315 to 400 nm.
    GO:0006950    response to stress    Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a disturbance in organismal or cellular homeostasis, usually, but not necessarily, exogenous (e.g. temperature, humidity, ionizing radiation).
    GO:0007435    salivary gland morphogenesis    The process in which the anatomical structures of the salivary gland are generated and organized.
    GO:0007165    signal transduction    The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.
    GO:0016337    single organismal cell-cell adhesion    The attachment of one cell to another cell via adhesion molecules, where both cells are part of the same organism.
    GO:0007169    transmembrane receptor protein tyrosine kinase signaling pathway    A series of molecular signals initiated by the binding of an extracellular ligand to a receptor on the surface of the target cell where the receptor possesses tyrosine kinase activity, and ending with regulation of a downstream cellular process, e.g. transcription.
cellular component
    GO:0030122    AP-2 adaptor complex    A heterotetrameric AP-type membrane coat adaptor complex that consists of alpha, beta2, mu2 and sigma2 subunits, and links clathrin to the membrane surface of a vesicle, and the cargo receptors during receptor/clathrin mediated endocytosis. Vesicles with AP-2-containing coats are normally found primarily near the plasma membrane, on endocytic vesicles. In at least humans, the AP-2 complex can be heterogeneric due to the existence of multiple subunit isoforms encoded by different alpha genes (alphaA and alphaC).
    GO:0005794    Golgi apparatus    A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions.
    GO:0000139    Golgi membrane    The lipid bilayer surrounding any of the compartments of the Golgi apparatus.
    GO:0070435    Shc-EGFR complex    A protein complex that contains the epidermal growth factor receptor (EGFR) and the adaptor protein Shc, and is involved in linking EGFR activation to the p21-Ras pathway.
    GO:0016323    basolateral plasma membrane    The region of the plasma membrane that includes the basal end and sides of the cell. Often used in reference to animal polarized epithelial membranes, where the basal membrane is the part attached to the extracellular matrix, or in plant cells, where the basal membrane is defined with respect to the zygotic axis.
    GO:0009986    cell surface    The external part of the cell wall and/or plasma membrane.
    GO:0005737    cytoplasm    All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
    GO:0031901    early endosome membrane    The lipid bilayer surrounding an early endosome.
    GO:0030139    endocytic vesicle    A membrane-bounded intracellular vesicle formed by invagination of the plasma membrane around an extracellular substance. Endocytic vesicles fuse with early endosomes to deliver the cargo for further sorting.
    GO:0005783    endoplasmic reticulum    The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
    GO:0005789    endoplasmic reticulum membrane    The lipid bilayer surrounding the endoplasmic reticulum.
    GO:0005768    endosome    A vacuole to which materials ingested by endocytosis are delivered.
    GO:0010008    endosome membrane    The lipid bilayer surrounding an endosome.
    GO:0005576    extracellular region    The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
    GO:0005615    extracellular space    That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
    GO:0005925    focal adhesion    Small region on the surface of a cell that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments.
    GO:0016021    integral component of membrane    The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
    GO:0005622    intracellular    The living contents of a cell; the matter contained within (but not including) the plasma membrane, usually taken to exclude large vacuoles and masses of secretory or ingested material. In eukaryotes it includes the nucleus and cytoplasm.
    GO:0016020    membrane    A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
    GO:0045121    membrane raft    Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
    GO:0097489    multivesicular body, internal vesicle lumen    The volume enclosed by the membrane of the multivesicular body internal vesicle.
    GO:0031965    nuclear membrane    Either of the lipid bilayers that surround the nucleus and form the nuclear envelope; excludes the intermembrane space.
    GO:0005634    nucleus    A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
    GO:0048471    perinuclear region of cytoplasm    Cytoplasm situated near, or occurring around, the nucleus.
    GO:0005886    plasma membrane    The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
    GO:0043235    receptor complex    Any protein complex that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.

 Visualization

(-) Interactive Views

Asymmetric Unit
  Complete Structure
    Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
    WebMol | AstexViewer[tm]@PDBe
(Java Applets, require no local installation except for Java; loading may be slow)
    STRAP
(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    RasMol
(require local installation)
    Molscript (VRML)
(requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)
 
  Ligands, Modified Residues, Ions
    AEE  [ RasMol | Jena3D ]  +environment [ RasMol | Jena3D ]
 
  Sites
    AC1  [ RasMol ]  +environment [ RasMol ]
 
  Cis Peptide Bonds
(no "Cis Peptide Bonds" information available for 2jiu)
 
Biological Units
  Complete Structure
    Biological Unit 1  [ Jena3D ]
    Biological Unit 2  [ Jena3D ]

(-) Still Images

Jmol
  protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick
Molscript
  protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick

 Databases and Analysis Tools

(-) Databases

Access by PDB/NDB ID
  2jiu
    Family and Domain InformationProDom | SYSTERS
    General Structural InformationGlycoscienceDB | MMDB | NDB | OCA | PDB | PDBe | PDBj | PDBsum | PDBWiki | PQS | PROTEOPEDIA
    Orientation in MembranesOPM
    Protein SurfaceSURFACE
    Secondary StructureDSSP (structure derived) | HSSP (homology derived)
    Structural GenomicsGeneCensus
    Structural NeighboursCE | VAST
    Structure ClassificationCATH | Dali | SCOP
    Validation and Original DataBMRB Data View | BMRB Restraints Grid | EDS | PROCHECK | RECOORD | WHAT_CHECK
 
Access by UniProt ID/Accession number
  EGFR_HUMAN | P00533
    Comparative Protein Structure ModelsModBase
    Genomic InformationEnsembl
    Protein-protein InteractionDIP
    Sequence, Family and Domain InformationInterPro | Pfam | SMART | UniProtKB/SwissProt
 
Access by Enzyme Classificator   (EC Number)
  2.7.1.112
    General Enzyme InformationBRENDA | EC-PDB | Enzyme | IntEnz
    PathwayKEGG | MetaCyc
 
Access by Disease Identifier   (MIM ID)
  (no 'MIM ID' available)
    Disease InformationOMIM
 
Access by GenAge ID
  0170
    Age Related InformationGenAge

(-) Analysis Tools

Access by PDB/NDB ID
    Domain InformationXDom
    Interatomic Contacts of Structural UnitsCSU
    Ligand-protein ContactsLPC
    Protein CavitiescastP
    Sequence and Secondary StructurePDBCartoon
    Structure AlignmentSTRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
    Structure and Sequence BrowserSTING
 
Access by UniProt ID/Accession number
  EGFR_HUMAN | P00533
    Protein Disorder PredictionDisEMBL | FoldIndex | GLOBPLOT (for more information see DisProt)

 Related Entries

(-) Entries Sharing at Least One Protein Chain (UniProt ID)

UniProtKB/Swiss-Prot
        EGFR_HUMAN | P005331dnq 1dnr 1ivo 1m14 1m17 1mox 1nql 1xkk 1yy9 1z9i 2eb2 2eb3 2exp 2exq 2gs2 2gs6 2gs7 2itn 2ito 2itp 2itq 2itt 2itu 2itv 2itw 2itx 2ity 2itz 2j5e 2j5f 2j6m 2jit 2jiv 2ks1 2m0b 2m20 2n5s 2rf9 2rfd 2rfe 2rgp 3b2u 3b2v 3bel 3buo 3c09 3g5v 3g5y 3gop 3gt8 3ika 3lzb 3njp 3ob2 3op0 3p0y 3pfv 3poz 3qwq 3ug1 3ug2 3vjn 3vjo 3vrp 3vrr 3w2o 3w2p 3w2q 3w2r 3w2s 3w32 3w33 4g5j 4g5p 4hjo 4i1z 4i20 4i21 4i22 4i23 4i24 4jq7 4jq8 4jr3 4jrv 4krl 4krm 4kro 4krp 4li5 4ll0 4lqm 4lrm 4r3p 4r3r 4r5s 4riw 4rix 4riy 4rj4 4rj5 4rj6 4rj7 4rj8 4tks 4uip 4uv7 4wd5 4wkq 4wrg 4zau 4zjv 4zse 5c8k 5c8m 5c8n 5cal 5can 5cao 5cap 5caq 5cas 5cau 5cav 5cnn 5cno 5czh 5czi 5d41 5edp 5edq 5edr 5em5 5em6 5em7 5em8 5fed 5fee 5feq 5gmp 5gnk 5hcx 5hcy 5hcz 5hg5 5hg7 5hg8 5hg9 5hib 5hic 5j9y 5j9z 5jeb 5lv6 5sx4 5sx5 5u8l 5ug8 5ug9 5uga 5ugb 5ugc

(-) Related Entries Specified in the PDB File

1dnq THEORETICAL MODEL OF THE FIRST AND SECOND DOMAINS OF THE HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR ECTODOMAIN
1dnr THEORETICAL MODEL OF THE THIRD AND FOURTH DOMAINS OF THE HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR ECTODOMAIN
1ivo CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN EPIDERMAL GROWTHFACTOR AND RECEPTOR EXTRACELLULAR DOMAINS.
1m14 TYROSINE KINASE DOMAIN FROM EPIDERMAL GROWTH FACTOR RECEPTOR
1m17 EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE DOMAINWITH 4-ANILINOQUINAZOLINE INHIBITOR ERLOTINIB
1mox CRYSTAL STRUCTURE OF HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR(RESIDUES 1-501) IN COMPLEX WITH TGF-ALPHA
1nql STRUCTURE OF THE EXTRACELLULAR DOMAIN OF HUMAN EPIDERMALGROWTH FACTOR (EGF) RECEPTOR IN AN INACTIVE (LOW PH)COMPLEX WITH EGF.
1xkk EGFR KINASE DOMAIN COMPLEXED WITH A QUINAZOLINE INHIBITOR-GW572016
1yy9 STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE EPIDERMALGROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OFCETUXIMAB/ERBITUX/ IMC-C225
1z9i A STRUCTURAL MODEL FOR THE MEMBRANE-BOUND FORM OF THEJUXTAMEMBRANE DOMAIN OF THE EPIDERMAL GROWTH FACTORRECEPTOR
2gs2 CRYSTAL STRUCTURE OF THE ACTIVE EGFR KINASE DOMAIN
2gs7 CRYSTAL STRUCTURE OF THE INACTIVE EGFR KINASE DOMAIN INCOMPLEX WITH AMP-PNP
2itn CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN G719S MUTATION IN COMPLEX WITH AMP-PNP
2ito CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN G719S MUTATION IN COMPLEX WITH IRESSA
2itp CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN G719S MUTATION IN COMPLEX WITH AEE788
2itq CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN G719S MUTATION IN COMPLEX WITH AFN941
2itt CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN L858R MUTATION IN COMPLEX WITH AEE788
2itu CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN L858R MUTATION IN COMPLEX WITH AFN941
2itv CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN L858R MUTATION IN COMPLEX WITH AMP-PNP
2itw CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AFN941
2itx CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AMP-PNP
2ity CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH IRESSA
2itz CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN L858R MUTATION IN COMPLEX WITH IRESSA
2j5e CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AN IRREVERSIBLE INHIBITOR 13- JAB
2j5f CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AN IRREVERSIBLE INHIBITOR 34- JAB
2j6m CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN IN COMPLEX WITH AEE788
2jit CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN T790M MUTATION
2jiv CRYSTAL STRUCTURE OF EGFR KINASE DOMAIN T790M MUTATION IN COMPEX WITH HKI-272